ECMO Working Group

Committee Description

SCA will be regarded as a key supporter and promoter of research related to cardiovascular and thoracic disease.

The mission of the working group is to become a leader in multi-center adult ECMO trials in the United States.

The purpose of the working group is to:

  1. Review current best practices in adult ECMO (from the published literature and expert opinion) and develop clinical guidelines for important aspects of clinical care.
  2. Foster multi-center collaboration for adult ECMO clinical trials in the United States and Canada.

The working group reports to the Quality & Safety Leadership Committee.

The working group meets at least once per year.

The working group is composed of 2 Co-Chairs, Parent Committee (QSL) Chair, and up to five other members. A Board Liaison may be appointed at the discretion of the President.

Working group members serve for a term of two years. 

Committee Members

Full Name Institution Committee Title Term Ends
Michael A. Mazzeffi, MD MPH University of Maryland Co-Chair April, 2021
Jacob Gutsche, MD Perelman School of Medicine University of PA Co-Chair April, 2021
Mauricio Del Rio, MD Duke University Medical Center Member April, 2021
Manuel Fontes, MD Yale University Member April, 2021
Mabel Chung, MD Massachusetts General Hospital Member April, 2021
Joseph Meltzer, MD UCLA Medical Center Member April, 2021
James Ramsay, MD University of California, San Francisco Member April, 2021
Antonio Hernandez, MD MSCI Vanderbilt University Member April, 2021
Amit Bardia, MD Yale University Member April, 2021